SCHEMBL1018899

SCHEMBL1018899

Cn1cc2c(n1)CCN(CC(=O)N1CCN(C3CCC3)CC1)C2

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
PARP1 P09874 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KMT2A Q03164 2/20 0.38
HRH3 Q9Y5N1 3/20 0.37
KCNH2 Q12809 1/20 0.37
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37
F10 P00742 2/20 0.36
TSHR P16473 1/20 0.36
PKM P14618 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017173 0.87 PARP1 (0.41) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL13985824 0.86 ALDH1A1 (0.44) PARP1ALDH1A1KDM4EHTTNPSR1
SCHEMBL1019037 0.85 SMN1; SMN2 (0.42) SMN1; SMN2PARP1ALDH1A1KDM4EHRH3
SCHEMBL1018095 0.83 HTT (0.38) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL1013793 0.83 HRH3 (0.38) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL1017564 0.83 HRH3 (0.39) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL1018826 0.83 KDM4E (0.39) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL1014999 0.82 HRH3 (0.38) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL13748292 0.82 HRH3 (0.43) SMN1; SMN2PARP1ALDH1A1KDM4EHTT
SCHEMBL1017656 0.81 HTT (0.39) SMN1; SMN2PARP1ALDH1A1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 SMN1; SMN2 1615/4885PARP1 3633/4885ALDH1A1 1229/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 SMN1; SMN2 1615/4885PARP1 3633/4885ALDH1A1 1229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.